Clinical Trial Update: Sorafenib Chemoembolization Evaluation Controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sorafenib in combination with hepatic chemoembolization for hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED